Acth and Glimepiride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acth (corticotropin) and Glimepiride (glimepiride). Common drug interactions include lung disorder among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Acth and Glimepiride. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Acth?

Acth has active ingredients of corticotropin. eHealthMe is studying from 5,402 Acth users. Check the latest studies of Acth.

What is Glimepiride?

Glimepiride has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 45,909 Glimepiride users. Check the latest studies of Glimepiride.

On Jul, 29, 2026

12 people who take Acth and Glimepiride together, and have interactions are studied.

What are the common drug interactions of Acth and Glimepiride, by gender? *:

female:

Lung disorder (lung disease)
Blood glucose increased
Drug ineffective
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Localised oedema (fluid retention in a particular part of the body)
Oedema peripheral (superficial swelling)
Anticoagulation drug level below therapeutic
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)

male:

Asthenia (weakness)
Blood potassium decreased
Dehydration (dryness resulting from the removal of water)
Fatigue (feeling of tiredness)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Hypotension (abnormally low blood pressure)
Protein urine present
Dyspnoea (difficult or laboured respiration)
Hypertension (high blood pressure)
Lung carcinoma cell type unspecified recurrent (lung cancer reoccurrence)

What are the common drug interactions of Acth and Glimepiride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hypertension (high blood pressure)

60+:

Blood glucose increased
Drug ineffective
Hypertension (high blood pressure)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Localised oedema (fluid retention in a particular part of the body)
Oedema peripheral (superficial swelling)
Protein urine present
Anticoagulation drug level below therapeutic

What are the existing conditions these people have? *

Pulmonary Sarcoidosis (growth of tiny collections of inflammatory cells in lungs): 3 people, 25.00%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 3 people, 25.00%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 16.67%
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 1 person, 8.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
Joint Pain: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Acth and Glimepiride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously